Keynote speakers where announced for the 2018 ISPE Annual Meeting & Expo. Taking place in Philadelphia, Pennsylvania, November 4–7, keynote addresses will showcase global pharmaceutical industry leaders offering compelling and enlightening presentations on industry-critical technical developments.
As Novo Nordisk moves toward a regulatory submission of its new oral semaglutide, Lars will offer his perspective on how to strive for leadership in diabetes management and simultaneously provide groundbreaking innovation in manufacturing.
Pharmaceutical manufacturing and supply organizations respond to high expectations from R&D and commercial organizations, regulators, and shareholders. Kirsten will discuss how Pfizer’s global supply team manages these expectations, emerging technologies, and complex supply chains to deliver important medicines to patients now and in the future.
Development and delivery of gene and cell therapies in clinical and commercial settings present new challenges for biotech companies and their partners, and new opportunities to innovate at all levels, including manufacturing. Nick’s presentation will delve into the ways that companies can leverage in-house capabilities and strategic partnerships to deliver cutting edge therapies to patients with genetic diseases and cancer, and what’s still needed in order to make these therapies widely available.
The pharmaceutical industry’s work has a major impact on the health and lives of patients who benefit from today’s medicines. Becky will share her personal journey of living with diabetes and the possibilities that emerging therapies offer to enhance the lives of other patients.
The 2018 ISPE Annual Meeting & Expo delivers a broad spectrum of technical education for multiple levels of expertise across six tracks, five technical workshops, and more than 50 education sessions. In addition, an extensive Expo will showcase more than 300 companies offering advanced technologies and services.